Yafei Yang is a postdoctoral fellow at the Third Affiliated Hospital of Shenzhen University, focusing on tumor genomics and translational cancer pharmacology. He has research experience particularly in the preclinical evaluation of small molecule inhibitors targeting transcriptional regulation in cancer. Dr. Yang has published >10 peer-reviewed publications in various journals. He has published studies on CDK7 blockade to suppress super-enhancer-associated oncogenes in bladder cancer and the application of the small molecule inhibitor THZ1 for therapeutic intervention in bladder cancer, contributing to the exploration of novel molecular targets and pharmacological strategies in oncology.